Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-006994
Filing Date
2022-03-16
Accepted
2022-03-16 16:38:20
Documents
56
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1120849
2 ex21-1.htm EX-21.1 3219
3 ex31-1.htm EX-31.1 18103
4 ex31-2.htm EX-31.2 18495
5 ex32-1.htm EX-32.1 9204
6 logo_001.jpg GRAPHIC 9984
7 logo_002.jpg GRAPHIC 6720
8 logo_003.jpg GRAPHIC 11706
  Complete submission text file 0001493152-22-006994.txt   4096884

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE vicp-20211231.xsd EX-101.SCH 27566
10 XBRL CALCULATION FILE vicp-20211231_cal.xml EX-101.CAL 37720
11 XBRL DEFINITION FILE vicp-20211231_def.xml EX-101.DEF 141797
12 XBRL LABEL FILE vicp-20211231_lab.xml EX-101.LAB 250358
13 XBRL PRESENTATION FILE vicp-20211231_pre.xml EX-101.PRE 205873
50 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 425751
Mailing Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041
Business Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041 470-514-4013
Vicapsys Life Sciences, Inc. (Filer) CIK: 0001468639 (see all company filings)

EIN.: 621153426 | State of Incorp.: FL
Type: 10-K | Act: 34 | File No.: 000-56145 | Film No.: 22745371
SIC: 2834 Pharmaceutical Preparations